Skip to main content

Daily Download

Cancer.EULAR.PTC.Cancer

2024 EULAR Points to consider when treating patients with cancer

2024 EULAR Points to consider when using targeted therapies in patients with inflammatory arthritis and a history of cancer

MyCancelledLecture

My Cancelled Lecture Slides

Dr. Jack Cush records his "Life Lessons (that keep changing) in Rheumatology Lecture. 

RA,Treatment

Rheumatoid Arthritis - Treatment

A slides set on RA Treatment options with MTX teaching slides

Preclinical,RA,Trials,Grid

Pre-Clinical RA - Clinical Trial Outcomes

Pivotal Trials in at-risk patients.

Private practice vs academia

Private Practice vs Academic Medicine

The pros and cons of Private Practice vs. Academic Medicine. - submitted by Kathryn Dao, MD

ACR vs EULAR guidelines 2022

Comparing ACR21 vs EULAR22 RA Guidelines

Distinguishing features between the 2021 ACR and 2022 EULAR RA treatment guidelines

JAK,FDA,EMA,regulatory

JAKi Regulatory Decisions - FDA, EMA, Canada

Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).

trials,grid

Arthritis Clinical Trials Comparison Grid

Use this resource to keep track of your clinical trials and key information needed when communicating with patients about a drug study.

AOSD,2nd

Diagnosis & Treatment of Still's Disease

Outcomes, misdiagnosis, diagnosis, Diagnostic criteria and treatmenet options for AOSD